Riding Covid Vaccine Highs, CanSino Plans Swiss Listing
The first vaccine stock to be listed in the both Mainland China and Hong Kong will issue global depositary receipts (GDRs) in SwitzerlandKey Takeaways:After successful listings in Shanghai and Hong…
Recent Articles
RELATED ARTICLES
-
Fosun Pharma, CanSino take different paths as Covid lift fade
2196.HK 6185.HK
- Health Guard plans dual listing to fund HPV vaccine fight
-
With healthier finances, Clover Bio shifts to flu and RSV vaccines
2197.HK
- China’s mRNA pioneer Stemirna faces post-Covid reinvention test
-
FAST NEWS: CanSino’s revenue plunges as demand dries up for Covid vaccines
6185.HK 688185.SHG
-
FAST NEWS: CanSino receives Gates Foundation grant to develop polio vaccine
6185.HK 688185.SHG
- CHINA BULLETIN: Weak Economic Signals All Around
Discover hidden China stock gems in our weekly newsletter